FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

GlaxoSmithkline Consmer Healthcare Panadol Recall

Panadol (acetaminophen) Extra Strength, 500 mg, a) 30 count (UPC 1-03-53100-91070-8

GlaxoSmithkline Consmer Healthcare · Moon Township, PA

Risk level
Class III
Reported by FDA
Aug 12, 2015
Recall ID
D-1287-2015
Check your lot numberHow we source this data

Summary

GlaxoSmithkline Consmer Healthcare recalled Panadol starting Jun 30, 2015. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1287-2015 on Aug 12, 2015. Reason: Failed Dissolution Specifications. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications

Product description

Panadol (acetaminophen) Extra Strength, 500 mg, a) 30 count (UPC 1-03-53100-91070-8, NDC 0135-0135-02), b) 60 count (UPC 1-03-53100-91080-7, NDC 0135-0135-03) and c) 100 count (UPC 1-03-53100-91090-6, NDC 0135-0135-04) bottles, Distributed by: GlaxoSmithKline Consumer Healthcare L.P, Moon Township, PA 15108

Lot numbers, UPCs & expiration codes

a) 13034 exp 10/31/15, 13222 and 13337 exp 11/30/15, 13611 and 13760 exp 2/29/15, 13953 exp 4/30/16, and 14542 exp 1/31/17; b) BT10114001 and BT10115001A exp 2/1/18, 13316 and 13438 exp 11/30/15 and 13880 exp 2/29/16; c) 13298 exp 11/30/15 and 13759 exp 4/30/16

Where it was sold

Puerto Rico and Virgin Islands

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1287-2015
Classification
Class III
Status
Terminated
Recall initiated
Jun 30, 2015
FDA report date
Aug 12, 2015
Quantity
17,675 cases
Recall type
Voluntary: Firm initiated
Recalling firm
GlaxoSmithkline Consmer Healthcare

Original FDA data

Every field from FDA enforcement report D-1287-2015, exactly as published.

Show all FDA fields
City
Moon Township
State
PA
Status
Terminated
Country
United States
Event ID
71717
Address
1000 GSK Drive
Code information
a) 13034 exp 10/31/15, 13222 and 13337 exp 11/30/15, 13611 and 13760 exp 2/29/15, 13953 exp 4/30/16, and 14542 exp 1/31/17; b) BT10114001 and BT10115001A exp 2/1/18, 13316 and 13438 exp 11/30/15 and 13880 exp 2/29/16; c) 13298 exp 11/30/15 and 13759 exp 4/30/16
Postal code
15108
Report date
Aug 12, 2015
Product type
Drugs
Recall number
D-1287-2015
Classification
Class III
Recalling firm
GlaxoSmithkline Consmer Healthcare
Product quantity
17,675 cases
Termination date
Feb 28, 2017
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Panadol (acetaminophen) Extra Strength, 500 mg, a) 30 count (UPC 1-03-53100-91070-8, NDC 0135-0135-02), b) 60 count (UPC 1-03-53100-91080-7, NDC 0135-0135-03) and c) 100 count (UPC 1-03-53100-91090-6, NDC 0135-0135-04) bottles, Distributed by: GlaxoSmithKline Consumer Healthcare L.P, Moon Township, PA 15108
Distribution pattern
Puerto Rico and Virgin Islands
Recall initiation date
Jun 30, 2015
Initial firm notification
Letter
Center classification date
Aug 5, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1287-2015, published Aug 12, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls